Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.

Join us for an insightful Q&A with Jonathan Meyer, MD, voluntary clinical professor of psychiatry at the University of California, San Diego, while he delves into why lithium is heralded as the gold standard mood stabilizer for patients with bipolar disorder with a history of mania. Dr Meyer discusses the limited evidence-based options available, the unique benefits of lithium, and how it stands out despite the adverse effects associated with its use. Gain valuable knowledge on optimizing lithium treatment, managing its side effects, and understanding its critical role in both acute mania and long-term maintenance.